Farallon Capital Management LLC

Australian firm Nexvet scores $31.5M to expand clinical program for pets' health

Melbourne, Australia-based animal therapeutics developer Nexvet Biopharma scored $31.5 million in a funding round from investors and shareholders to expand its product portfolio and clinical program for pets' health.

Read Full Article

Farallon Acquires Tinkler’s Whitehaven Stake, Buys More

Farallon Capital Management LLC acquired 9.91% stake from Nathan Tinkler making the fund the largest shareholder at Whitehaven Coal Ltd.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics